ORGANIZATION OVERVIEW Ranbaxy Laboratories Limited (Ranbaxy)‚ is an integrated‚ research based‚ international pharmaceutical company‚ producing a wide range of quality‚ affordable generic medicines. Ranbaxy today has a presence in 23 of the top 25 pharmaceutical markets of the world. The Company has a global footprint in 46 countries‚ world-class manufacturing facilities in 7 countries and serves customers in over 125 countries. Ranbaxy was incorporated in 1961 and went public in 1973. For the
Premium Business process reengineering Supply chain management Enterprise resource planning
Formation Ranbaxy was started by Ranbir Singh and Gurbax Singh in 1937 as a distributor for a Japanese company Shionogi. The name Ranbaxy is a combination of the names of its first owners Ranbir and Gurbax. Bhai Mohan Singh bought the company in 1952 from his cousins Ranbir and Gurbax. After Bhai Mohan Singh’s son Parvinder Singh joined the company in 1967‚ the company saw an increase in scale. His sons Malvinder Mohan Singh and Shivinder Mohan Singh sold the company to the Japanese company Daiichi Sankyo
Premium Ranbaxy Laboratories Generic drug
Ranbaxy Laboratories Ltd. (RLL) is the largest pharmaceutical company incorporated in India. It is also amongst the top league globally and is ranked 9th largest generic company worldwide. Ranbaxy is also credited with the tag of true Indian multinational. The company traces its roots to a chemist shop in Delhi. It is one of the first Indian pharmaceutical company to start a joint venture abroad. Rapid growth of Ranbaxy is attributed mainly to its focused research and joint ventures in India and
Premium Generic drug Marketing Ranbaxy Laboratories
in the global healthcare arena and Ranbaxy endeavors to be at the forefront in delivering the India centric advantages to the advanced and developing countries of the world. From a small domestic company at inception‚ Ranbaxy has grown formidably to be a Billion dollar institution that was envisioned by Late Dr Parvinder Singh‚ Chairman and Managing Director‚ Ranbaxy in early 90’s. It is with the unwavering ’ dedication ’ and the ’ will to win ’ of Team Ranbaxy across the globe that it has traversed
Premium Human resource management
Summary This case explores the possibility of a brand extension for Revital‚ the bestselling vitamin and mineral supplement and number-one nutraceutical brand in India and a top Ranbaxy Global Consumer Healthcare product. The case examines Revital’s shift from a prescription product to a popular over-the-counter (OTC) brand and explores Ranbaxy’s strategies to position Revital as the brand with the highest recall. It assesses Revital’s competitors in India’s booming nutraceutical market in a scenario
Free Target market Marketing Caffeine
FUKUSHIMA DAIICHI NUCLEAR DISASTER Date: March 11‚ 2011 Location: Ōkuma‚ Fukushima‚ Japan Construction began: July 25‚ 1967 (Fukushima I - 1) Commission date: March 26‚ 1971 (Fukushima I - 1) Operator(s): Tokyo Electric Power Company (TEPCO) Constructor(s): Kajima Injuries: 37 with physical injuries‚ 2 workers taken to hospital with radiation burns. THE POWERPLANT The Fukushima I Nuclear Power Plant also known as Fukushima Dai-ichi (dai-ichi means "number one")‚ is a disabled nuclear
Premium Chernobyl disaster Nuclear power Nuclear safety
I would like to especially thank my Professors- Mr. Y G Chouksey‚ my oldest friend and source of inspiration in the institute; Mr. S Jayaraman How can I forget to thank Mr. Vimlendu K Singh (GM-API Business‚ Ranbaxy Laboratories Ltd)‚ due to whom my dream of working with Ranbaxy came to a reality. My sincere thanks to him for all his support and efforts to make me comfortable in the organization. And lastly my thank to the one who is my most consistent friend. He never speaks to me‚ yet
Premium Generic drug Ranbaxy Laboratories Pharmaceutical industry
| Corporate Social Responsibility Report: RANBAXY LABORATORIES LTD | | ABSTRACT This report explores the Millennium Development Goals related to Healthcare at global and national level. It also focuses on the diseases that are prevalent in India and the steps taken by Ranbaxy towards the eradication of these diseases. It reviews the activities of Ranbaxy Laboratories towards the welfare of community and the protection of environment. It also throws light on the efforts done by the company in
Premium Millennium Development Goals Mortality rate Malaria
A Project report on Financial Analysis of Ranbaxy Laboratories Limited Index S. No. Content Page No. 1 Executive Summary of ‘Ranbaxy Laboratories Limited’ 3 2 Capital Expenditure at Ranbaxy 7 3 Account Balances for properties‚ plant and equipment 8 4 Capital Structure at Ranbaxy 9 5 Beta measure of the company 11 6 Weighted Average cost of capital 13 7 Debt-Equity ratio 14 8 Du Pont Analysis 15 9 Comments
Premium Financial ratios Inventory Generic drug
I.I.F.T.R Subject: Mergers and Acquisitions Submitted to: Prof. Dipesh Agrawal Mergers And Acquisition Synopsis: Introduction Definition What makes Mergers and Acquisitions Difference between Mergers and Acquisition Advantages Disadvantages Examples Conclusion Introduction Mergers and Acquisitions refers to the aspect of corporate strategy‚ corporate finance and management dealing
Premium Mergers and acquisitions